Dr. Gail Lebovic, MD

NPI: 1003975525
Total Payments
$10.5M
2024 Payments
$31.90
Companies
5
Transactions
13

Payment Breakdown by Category

Other$10.5M (100.0%)
Food & Beverage$635.29 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Current or prospective ownership or investment interest $10.5M 2 100.0%
Food and Beverage $635.29 10 0.0%
Unspecified $0 1 0.0%

Payments by Type

General
$10.5M
12 transactions
Ownership
$0
1 transactions

Top Paying Companies

Company Total Records Latest Year
Focal Therapeutics, Inc. $10.5M 5 $0 (2018)
Stryker Corporation $148.85 2 $0 (2019)
Allergan, Inc. $62.29 3 $0 (2022)
ABBVIE INC. $61.70 2 $0 (2024)
HOLOGIC INC $17.45 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $31.90 1 ABBVIE INC. ($31.90)
2023 $29.80 1 ABBVIE INC. ($29.80)
2022 $27.73 1 Allergan, Inc. ($27.73)
2019 $183.41 4 Stryker Corporation ($148.85)
2018 $10.5M 5 Focal Therapeutics, Inc. ($10.5M)
2017 $0 1 Focal Therapeutics, Inc.

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/27/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $31.90 General
Category: FACIAL AESTHETICS
01/28/2023 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $29.80 General
Category: FACIAL AESTHETICS
01/19/2022 Allergan, Inc. BOTOX (Biological) Food and Beverage In-kind items and services $27.73 General
Category: FACIAL AESTHETICS
07/17/2019 Stryker Corporation SURG - NEPTUNE (Device) Food and Beverage Cash or cash equivalent $116.37 General
Category: SURGICAL
07/17/2019 Stryker Corporation SURG - NEPTUNE (Device) Food and Beverage Cash or cash equivalent $32.48 General
Category: SURGICAL
03/27/2019 Allergan Inc. BOTOX COSMETIC (Biological) Food and Beverage In-kind items and services $17.93 General
01/02/2019 Allergan Inc. Food and Beverage In-kind items and services $16.63 General
10/01/2018 Focal Therapeutics, Inc. Current or prospective ownership or investment interest Stock option $5,714,113.59 General
10/01/2018 Focal Therapeutics, Inc. Current or prospective ownership or investment interest Stock option $4,744,654.56 General
06/26/2018 HOLOGIC INC Food and Beverage In-kind items and services $17.45 General
06/07/2018 Focal Therapeutics, Inc. BioZorb (Device) Food and Beverage In-kind items and services $195.00 General
Category: Tissue Marker
03/12/2018 Focal Therapeutics, Inc. BioZorb (Device) Food and Beverage In-kind items and services $150.00 General
Category: Tissue Marker
2017 Focal Therapeutics, Inc. $0.00 Ownership

About Dr. Gail Lebovic, MD

Dr. Gail Lebovic, MD is a Plastic and Reconstructive Surgery healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003975525.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gail Lebovic, MD has received a total of $10.5M in payments from pharmaceutical and medical device companies, with $31.90 received in 2024. These payments were reported across 13 transactions from 5 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($10.5M).

Practice Information

  • Specialty Plastic and Reconstructive Surgery
  • Location Dallas, TX
  • Active Since 12/08/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2086S0122X
  • Entity Type Individual
  • NPI Number 1003975525

Products in Payments

  • BioZorb (Device) $345.00
  • SURG - NEPTUNE (Device) $148.85
  • BOTOX (Biological) $89.43
  • BOTOX COSMETIC (Biological) $17.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Plastic and Reconstructive Surgery Doctors in Dallas